Evidence map›Paper›PMID 40904239›Full record

ArticleThoracic cancer2025

Anaplastic Lymphoma Kinase-Rearranged Chest Wall-Undifferentiated Small Round Cell Sarcoma With Massive Pleural Effusion and Rapid Progression: A Case With Autopsy Report.

Toshiki Amioka, Kaori Okayasu, Shoko Iwanaga, Mio Yamamoto, Mizuho Tosaka, Toshihisa Ishikawa, Tsutomu Kawasaki, Takehiko Shimoyama, Jiro Kumagai

Abstract readCase Reports
In one paragraph

Article in Thoracic cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Toshiki AmiokaYokohama City Minato Red Cross Hospital, Respiratory Medicine, Yokohama, Kanagawa, Japan.ORCID https://orcid.org/0009-0000-2450-5263
Kaori OkayasuYokohama City Minato Red Cross Hospital, Respiratory Medicine, Yokohama, Kanagawa, Japan.ORCID https://orcid.org/0000-0001-8917-5365
Shoko IwanagaYokohama City Minato Red Cross Hospital, Respiratory Medicine, Yokohama, Kanagawa, Japan.
Mio YamamotoYokohama City Minato Red Cross Hospital, Respiratory Medicine, Yokohama, Kanagawa, Japan.
Mizuho TosakaYokohama City Minato Red Cross Hospital, Respiratory Medicine, Yokohama, Kanagawa, Japan.
Toshihisa IshikawaYokohama City Minato Red Cross Hospital, Respiratory Medicine, Yokohama, Kanagawa, Japan.
Tsutomu KawasakiYokohama City Minato Red Cross Hospital, Respiratory Medicine, Yokohama, Kanagawa, Japan.
Takehiko ShimoyamaYokohama City Minato Red Cross Hospital, Thoracic Surgery, Yokohama, Kanagawa, Japan.
Jiro KumagaiYokohama City Minato Red Cross Hospital, Pathology, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chest wall sarcomas are rare and may exhibit aggressive behavior, posing diagnostic challenges-particularly in young adults. Although multidisciplinary treatments involving chemotherapy, radiotherapy, and surgery are recommended, prognosis remains poor. We report a case of a 43-year-old man referred with left-sided chest pain, dyspnea, and massive pleural effusion. Cytological analysis of the effusion and biopsy revealed small, round, atypical cells, and initial immunohistochemistry suggested Ewing sarcoma. During workup, the patient's symptoms worsened, tumor lysis syndrome developed, and he died on hospital day 28. Autopsy and extended immunohistochemical testing indicated small round cell sarcoma. Molecular analysis identified an echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion gene. The final diagnosis was small round cell sarcoma with EML4-ALK fusion originating from the thoracic wall. This case highlights the importance of early presentation and timely diagnosis using next generation sequencing to facilitate targeted therapy for ALK-rearranged chest wall sarcomas and improve patient outcomes.

Indexed as

Anaplastic Lymphoma KinaseOncogene Proteins, FusionPleural EffusionSarcoma, Small CellThoracic NeoplasmsThoracic WallAdultAutopsyDisease ProgressionGene RearrangementHumansMaleALK protein, humanAnaplastic Lymphoma KinaseOncogene Proteins, Fusionchest wallEML4‐ALKpleural effusionsmall round cell sarcoma

Identifiers

PMID40904239
PMCPMC12409067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.